FDA Inspection 1096855 — SGS Institut Fresenius Berlin GmbH & Co. KG
The FDA completed an inspection of SGS Institut Fresenius Berlin GmbH & Co. KG on June 17, 2019 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Berlin (Germany)